Alamar Biosciences Statistics
Total Valuation
ALMR has a market cap or net worth of $2.27 billion. The enterprise value is $2.07 billion.
| Market Cap | 2.27B |
| Enterprise Value | 2.07B |
Important Dates
The last earnings date was Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALMR has 69.39 million shares outstanding.
| Current Share Class | 69.39M |
| Shares Outstanding | 69.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +378.52% |
| Owned by Insiders (%) | 10.44% |
| Owned by Institutions (%) | 28.95% |
| Float | 36.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.60 |
| Forward PS | 16.33 |
| PB Ratio | 7.25 |
| P/TBV Ratio | 7.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.85, with a Debt / Equity ratio of 0.16.
| Current Ratio | 11.85 |
| Quick Ratio | 9.67 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -54.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -11.22% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $351,119 |
| Profits Per Employee | -$173,640 |
| Employee Count | 286 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALMR has paid $1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 27.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 58.14 |
| Average Volume (20 Days) | 330,877 |
Short Selling Information
The latest short interest is 2.43 million, so 3.50% of the outstanding shares have been sold short.
| Short Interest | 2.43M |
| Short Previous Month | 2.25M |
| Short % of Shares Out | 3.50% |
| Short % of Float | 6.72% |
| Short Ratio (days to cover) | 9.35 |
Income Statement
In the last 12 months, ALMR had revenue of $100.42 million and -$49.66 million in losses. Loss per share was -$2.10.
| Revenue | 100.42M |
| Gross Profit | 58.91M |
| Operating Income | -40.74M |
| Pretax Income | -48.63M |
| Net Income | -49.66M |
| EBITDA | -37.48M |
| EBIT | -40.74M |
| Loss Per Share | -$2.10 |
Balance Sheet
The company has $250.05 million in cash and $51.41 million in debt, with a net cash position of $198.65 million or $2.86 per share.
| Cash & Cash Equivalents | 250.05M |
| Total Debt | 51.41M |
| Net Cash | 198.65M |
| Net Cash Per Share | $2.86 |
| Equity (Book Value) | 312.86M |
| Book Value Per Share | 4.51 |
| Working Capital | 303.42M |
Cash Flow
In the last 12 months, operating cash flow was -$60.33 million and capital expenditures -$8.31 million, giving a free cash flow of -$68.64 million.
| Operating Cash Flow | -60.33M |
| Capital Expenditures | -8.31M |
| Depreciation & Amortization | 3.26M |
| Net Borrowing | 60.35M |
| Free Cash Flow | -68.64M |
| FCF Per Share | -$0.99 |
Margins
Gross margin is 58.66%, with operating and profit margins of -40.57% and -49.45%.
| Gross Margin | 58.66% |
| Operating Margin | -40.57% |
| Pretax Margin | -48.42% |
| Profit Margin | -49.45% |
| EBITDA Margin | -37.33% |
| EBIT Margin | -40.57% |
| FCF Margin | n/a |
Dividends & Yields
ALMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.19% |
| FCF Yield | -3.02% |
Analyst Forecast
The average price target for ALMR is $33.40, which is 2.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.40 |
| Price Target Difference | 2.14% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 44.56% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALMR has an Altman Z-Score of 12.1.
| Altman Z-Score | 12.1 |
| Piotroski F-Score | n/a |